Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Long COVID-19: early-phase trial registry
7 of 15 indexed Long COVID-19 trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #1,140 of 28,707 conditions by registered trial count.
15 US clinical trials · 7 currently recruiting · #1,140 of 28,707 conditions by registered trial count
Long COVID-19: 15 US clinical trials tracked, 7 recruiting.
Long COVID-19 is the subject of 15 registered US clinical trials on ClinicalTrials.gov, 7 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 8 in Phase 1-2 (earlier-stage). The most active sponsor is Duke University, running 5 of these trials.
Enrollment posture brief
Registry condition long-covid-19
OPEN 7 | RECR 47% | LATE 1 | EARLY 8 | RANK #1140 | SPON 5
Volume-matched condition peers
Nearest open-share peer: Autism (47% recruiting · 105 trials)
Long COVID-19 lists 7 open slots (47% of 15 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Long COVID-19 on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Long COVID-19 recruits in line with its size-band peers.
7 of 15 indexed trials (46.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Long COVID-19 research.
Duke University accounts for 5 of 15 trials (33.3%). 11 distinct sponsors appear on at least one study for this condition label.
-
Typical Long COVID-19 enrolment sits around 300 participants.
Median target enrolment is 300 among the 15 trials that report a genuine target (sentinel values excluded). 5 of those (33.3%) plan for fewer than 100 participants.
-
Long COVID-19 research is mostly interventional.
14 interventional and 1 observational studies make up this index (93.3% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
15 total, page 1 of 1
The Long COVID-19 Wearable Device Study
Scripps Translational Science Institute
NCT05741112
Long-Covid-19 Alleviation Through Learning Mindfulness Study
Columbia University
NCT07140094
AT1001 for the Treatment of Long COVID
Massachusetts General Hospital
NCT05747534
Low Dose Sirolimus in People With Post-Acute Sequelae of COVID-19 (PASC) Long COVID-19
Icahn School of Medicine at Mount Sinai
NCT06960928
Effect of 2-HOBA in Persistent Immune Activation in Long COVID POTS
Vanderbilt University Medical Center
NCT07189936
A Study to Examine Anktiva for the Treatment of COVID-19.
ImmunityBio
NCT07123727
Study of Liraglutide (A Weight Loss Drug) in High Risk Obese Participants With Cognitive and Memory Issues
University of Chicago
NCT06171152
RECOVER-SLEEP: Platform Protocol, Appendix_B (CPSD)
Duke University
NCT06404112
RECOVER-SLEEP: Platform Protocol, Appendix_A (Hypersomnia)
Duke University
NCT06404099
RECOVER-ENERGIZE Platform Protocol_Appendix A (Exercise Intolerance)
Duke University
NCT06404060
Long COVID-19 Cutaneous Signatures: An ARPA Funded Research Project
CND Life Sciences
NCT07005947
RECOVER-AUTONOMIC: Platform Protocol, Appendix A (IVIG)
Kanecia Obie Zimmerman
NCT06305793
A Pilot rTMS Trial for Neuropsychiatric Symptoms of Long-COVID
University of California, Los Angeles
NCT06586398
RECOVER-SLEEP: Platform Protocol
Duke University
NCT06404086
RECOVER-NEURO: Platform Protocol, Appendix_A to Measure the Effects of BrainHQ, PASC CoRE and tDCS Interventions on Long COVID Symptoms
Duke University
NCT05965739
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 7 |
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Long COVID-19 records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Long COVID-19 trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Long COVID-19 page
15 registered trials, 7 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 7 Long COVID-19 trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Duke University sponsors the most Long COVID-19 trials on record, review their full trial history before evaluating a specific study. See Duke University's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Long COVID-19 condition card totals 15 registered trials; most-linked intervention Solriamfetol Placebo; top US site state North Carolina. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.